immagine

Attività svolta

Desidero ricevere una copia cartacea
Informativa sulla privacy
Iscrizione alla newsletter

Diagnosi e presa in carico della borreliosi di Lyme nel cane

Bibliografia

1. Adeolu M, Gupta RS. A phylogenomic and molecular marker-based proposal for the division of the genus Borrelia into two genera: the emended genus Borrelia containing only the members of the relapsing fever Borrelia, and the genus Borreliella gen. nov. containing the members of the Lyme disease Borrelia (Borrelia burgdorferi sensu lato complex). Antonie Van Leeuwenhoek. 2014;105(6):1049-1072.

2. Appel MJ, Allan S, Jacobson RH et coll. Experimental Lyme disease in dogs produces arthritis and persistent infection. J. Infect. Dis. 1993;167:651-664.

3. Azuma Y, Kawamura K, Isogai H et coll. Neurologic abnormalities in two dogs with suspected Lyme disease. Microbiol. Immunol. 1993;37:325-329.

4. Baker CF, McCall JW, McCall SD et coll. Ability of an oral formulation of afoxolaner to protect dogs from Borrelia burgdorferi infection transmitted by wild Ixodes scapularis ticks. Comp. Immunol. Microbiol. Infect. Dis. 2016;49:65-69.

5. Barber RM, Li Q, Diniz PPVP et coll. Evaluation of brain tissue or cerebrospinal fluid with broadly reactive polymerase chain reaction for Ehrlichia, Anaplasma, spotted fever group Rickettsia, Bartonella, and Borrelia species in canine neurological diseases (109 cases). J. Vet. Intern. Med. 2010;24:372-378.

6. Barr SC. Treating Lyme-seropositive dogs. Clin. Brief Sound Board. 2012;5:8.

7. Beall MJ, Chandrashekar R, Eberts MD et coll. Serological and molecular prevalence of Borrelia burgdorferi, Anaplasma phagocytophilum, and Ehrlichia species in dogs from Minnesota. Vector Borne Zoonotic Dis. 2008;8:455-464.

8. Brisson D, Baxamusa N, Schwartz I et coll. Biodiversity of Borrelia burgdorferi strains in tissues of Lyme disease patients. PLoS One. 2011;6:e22926.

9. Burgio F, Meyer L, Armstrong R. A comparative laboratory trial evaluating the immediate efficacy of fluralaner, afoxolaner, sarolaner and imidacloprid permethrin against adult Rhipicephalus sanguineus (sensu lato) ticks attached to dogs. Parasit. Vectors. 2016;9:626.

10. Chandrashekar R, Beall MJ, Thatcher B et coll. Serologic responses to peptides of Anaplasma phagocytophilum and Borrelia burgdorferi in dogs infested with wild-caught Ixodes scapularis. Vet. J. 2017;226:6-11.

11. Cutler SJ, Ruzic-Sabljic E, Potkonjak A. Emerging borreliae - Expanding beyond Lyme borreliosis. Mol. Cell. Probes. 2017;31:22-27. 12. Detmer SE, Bouljihad M, Hayden DW et coll. Fatal pyogranulomatous myocarditis in 10 Boxer puppies. J. Vet. Diagn. Invest. 2016;28:144-149.

13. Duffy DC, Campbell SR. Ambient air temperature as a predictor of activity of adult Ixodes scapularis (Acari: Ixodidae). J. Med. Entomol. 1994;31:178-180.

14. Estrada-Peña A, Cutler S, Potkonjak A et coll. An updated meta-analysis of the distribution and prevalence of Borrelia burgdorferi s.l. in ticks in Europe. Int. J. Health Geog. 2018;17:41.

15. Garrade DD, Foley JE, Borjesson DL et coll. Canine granulocytic anaplasmosis: a review. J. Vet. Intern. Med. 2009;23:1129-1141.

16. Gerber B, Eichenberger S, Haug K et coll. Association of urine protein excretion and infection with Borrelia burgdorferi sensu lato in Bernese Mountain Dogs. Vet. J. 2009;182:487-488.

17. Gerber B, Haug K, Eichenberger S et coll. Follow-up of Bernese Mountain Dogs and other dogs with serologically diagnosed Borrelia burgdorferi infection: what happens to seropositive animals. BMC Vet. Res. 2009;5:18.

18. Gerber B, Eichenberger S, Wittenbrink MM et coll. Increased prevalence of Borrelia burgdorferi infections in Bernese Mountain Dogs: a possible breed predisposition. BMC Vet. Res. 2007;3:15.

19. Goldstein RE, Cordner AP, Sandler JL et coll. Microalbuminuria and comparison of serologic testing for exposure to Borrelia burgdorferi in nonclinical Labrador and golden retrievers. J. Vet. Diagn. Invest. 2007;19:294-297.

20. Hefty PS, Jolliff SE, Caimano MJ et coll. Changes in temporal and spatial patterns of outer surface lipoprotein expression generate population heterogeneity and antigenic diversity in the Lyme disease spirochete, Borrelia burgdorferi. Infect. Immun. 2002;70:3468-3478.

21. Honsberger NA, Six RH, Heinz TJ et coll. Efficacy of sarolaner in the prevention of Borrelia burgdorferi and Anaplasma phagocytophilum transmission from infected Ixodes scapularis to dogs. Vet. Parasitol. 2016;222:67-72.

22. Hutchinson ML, Strohecker MD, Simmons TW et coll. Prevalence rates of Borrelia burgdorferi (Spirochaetales: Spirochaetaceae), Anaplasma phagocytophilum (Rickettsiales: Anaplasmataceae), and Babesia microti (Piroplasmida: Babesiidae) in host-seeking Ixodes scapularis (Acari: Ixodidae) from Pennsylvania. J. Med. Entomol. 2015;52:693-698.

23. Goldstein RE, Brovida C, Fernandez-del Palacio MJ et coll. Iris glomerular disease study group, Consensus recommendations for treatment for dogs with serology positive glomerular disease. J. Vet. Intern. Med. 2013;27:S60-S66.

24. Jäderlund KH, Egenvall A, Bergstrom K et coll. Seroprevalence of Borrelia burgdorferi sensu lato and Anaplasma phagocytophilum in dogs with neurological signs. Vet. Rec. 2007;160:825-831. 25. Jäderlund KH, Bergstrom K, Egenvall A et coll. Cerebrospinal fluid PCR and antibody concentrations against Anaplasma phagocytophilum and Borrelia burgdorferi sensu lato in dogs with neurological signs. J. Vet. Intern. Med. 2009;23:669-672.

26. Kim SE, Kim S, Jeong M et coll. Experimental determination of a subantimicrobial dosage of doxycycline hyclate for treatment of periodontitis in Beagles. Am. J. Vet. Res. 2013;74:130- 135. 27. Koch HG. Seasonal incidence and attachment sites of ticks (Acari: Ixodidae) on domestic dogs in southeastern Oklahoma and northwestern Arkansas, USA. J. Med. Entomol. 1982;19:293-298.

28. Krimer PM, Miller AD, Li Q et coll. Molecular and pathological investigations of the central nervous system in Borrelia burgdorferi infected dogs. J. Vet. Diagn. Invest. 2011;23:757-763.

29. Layzell SJ, Bailey D, Peacey M et coll. Prevalence of Borrelia burgdorferi and Borrelia miyamotoi in questing Ixodes ricinus ticks from four sites in the UK. Ticks Tick-Borne Dis. 2018;9:217-224.

30. Lee X, Coyle DR, Johnson DK et coll. Prevalence of Borrelia burgdorferi and Anaplasma phagocytophilum in Ixodes scapularis (Acari: Ixodidae) nymphs collected in managed red pine forests in Wisconsin. J. Med. Entomol. 2014;51:694-701.

31. Levy SA, Magnarelli LA. Relationship between development of antibodies to Borrelia burgdorferi in dogs and the subsequent development of limb/joint borreliosis. J. Am. Vet. Med. Assoc. 1991;200:344-347.

32. Levy SA, Lissman BA, Ficke CM. Performance of a Borrelia burgdorferi bacterin in borreliosis-endemic areas. J. Am. Vet. Med. Assoc. 1993;202:1834-1838.

33. Levy S. Use of a C6 Elisa test to evaluate the efficacy of a whole-cell bacterin for the prevention of naturally transmitted canine Borrelia burgdorferi infection. Vet. Ther. 2002;3:420-424.

34. Levy SA, Clark KK, Glickman LT. Infection rates in dogs vaccinated and not vaccinated with an OspA Borrelia burgdorferi vaccine in a Lyme disease-endemic area of Connecticut. Int. J. Appl. Res. Vet. Med. 2005;3:1-5.

35. Levy SA, O’Connor TP, Hanscom JL et coll. Quantitative measurement of C6 antibody following antibiotic treatment of Borrelia burgdorferi antibody-positive nonclinical dogs. Clin. Vaccine Immunol. 2008;15:115-119.

36. Liang FT, Steere AC, Marques AR et coll. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE. J. Clin. Microbiol. 1999;37:3990-3996.

37. Littman MP, Goldstein RE. A matter of opinion: should we treat asymptomatic, nonproteinuric Lyme-seropositive dogs with antibiotics? Clin. Brief. 2011;9:13-16.

38. Littman MP. State-of-the-art-review: Lyme nephritis. J. Vet. Emerg. Crit. Care. 2013;23:163-173.

39. Littman MP. Borreliosis. In: Bonagura JD, Twedt DC eds. Kirk’s current veterinary therapy XV. St. Louis, Elsevier. 2014:1271-1275.

40. Littman MP, Goldstein RE. Vaccinating dogs against Lyme disease: two points of view. Today’s Vet. Pract. 2014;4:62-65.

41. Littman MP. Lyme disease. In: Ettinger SJ, Feldman EC, Cote E eds. Textbook of veterinary internal medicine. 8th edition. St. Louis, Elsevier. 2017:912-916.

42. Littman MP, Gerber B, Goldstein RE et coll. ACVIM consensus update on Lyme borreliosis in dogs and cats. J. Vet. Intern. Med. 2018;32:887-903.

43. Marchant A, Le Coupanec A, Joly C et coll. Infection of Ixodes ricinus by Borrelia burgdorferi sensu lato in peri-urban forests of France. PLoS One. 2017;12: e0183543. 44. Meeus P, Johnson J, Wagner B et coll. Antimicrobial activity of cefovecin (Convenia®) against Borrelia burgdorferi and its impact on early Lyme borreliosis in dogs. In: Proceedings of 30th ACVIM forum 2012. Available at www.vin.com/members/proceedings/proceedings.plx

45. Mitchell EB, McCall JW, Chester ST et coll. Efficacy of afoxolaner against Ixodes scapularis ticks in dogs. Vet. Parasitol. 2014;201:223-225.

46. Moody KD, Adams RL, Barthold SW. Effectiveness of antimicrobial treatment against Borrelia burgdorferi infection in mice. Antimicrob. Agents Chemother. 1994;38:1567-1572.

47. Moore GE, Guptill LF, Ward MP et coll. Adverse events diagnosed within three days of vaccine administration in dogs. J. Am. Vet. Med. Assoc. 2005;227:1102-1108.

48. Moroff S, Woodruff C, Woodring T et coll. Multiple antigen target approach using the Accuplex4 BioCD system to detect Borrelia burgdorferi antibodies in experimentally infected and vaccinated dogs. J. Vet. Diagn. Invest. 2015;27:581-588.

49. Philipp MT, Bowers LC, Fawcett PT et coll. Antibody response to IR6, a conserved immunodominant region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and in humans. J. Infect. Dis. 2001;184:870-878.

50. Piesman J, Gern L. Lyme borreliosis in Europe and North America. Parasitol. 2004;129:S191-S220.

51. Prusinski MA, Kokas JE, Hukey KT et coll. Prevalence of Borrelia burgdorferi (Spirochaetales: Spirochaetaceae), Anaplasma phagocytophilum (Rickettsiales: Anaplasmataceae), and Babesia microti (Piroplasmida: Babesiidae) in Ixodes scapularis (Acari: Ixodidae) collected from recreational lands in the Hudson Valley Region, New York State. J. Med. Entomol. 2014;51:226-236.

52. Radolf JD, Caimano MJ, Stevenson B et coll. Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes. Nat. Rev. Microbiol. 2012;10:87-99.

53. Raya AI, Afonso JC, Perez-Ecija RA et coll. Orbital myositis associated with Lyme disease in a dog. Vet. Rec. 2010;167:663-664.

54. Regier Y, Ballhorn W, Kempf VA. Molecular detection of Bartonella henselae in 11 Ixodes ricinus ticks extracted from a single cat. Parasit. Vectors. 2017;10:105.

55. Rhodes DVL, Earnhart CG, Mather TN et coll. Identification of Borrelia burgdorferi OspC genotypes in canine tissue following tick infestation: implications for Lyme disease vaccine and diagnostic assay design. Vet. J. 2013;198:412-418.

56. Six RH, Young DR, Myers MR et coll. Comparative speed of kill of sarolaner (Simparica) and afoxolaner (NexGard) against induced infestations of Ixodes scapularis on dogs. Parasit. Vectors. 2016;9:79.

57. Speck S, Reiner B, Streich WJ et coll. Canine borreliosis: a laboratory diagnostic trial. Vet. Microbiol. 2007;120:132-141.

58. Stanek G, Wormser GP, Gray J et coll. Lyme borreliosis. Lancet. 2012;379:461-473.

59. Strnad M, Hönig V, Růžek D et coll. Europe-wide meta-analysis of Borrelia burgdorferi sensu lato prevalence in questing Ixodes ricinus ticks. Appl. Environ. Microbiol. 2017;83:pii:e00609-17.

60. Straubinger RK, Rao TD, Davidson E et coll. Protection against tick-transmitted Lyme disease in dogs vaccinated with a multiantigenic vaccine. Vaccine. 2002;20:181-193.

61. Summers BA, Straubinger AF, Jacobson RH et coll. Histopathologic studies of experimental Lyme disease in the dog. J. Comp. Path. 2005;133:1-13.

62. Szekeres S, Lügner J, Fingerie V et coll. Prevalence of Borrelia miyamotoi and Borrelia burgdorferi sensu lato questing ticks from a recreational coniferous forest of East Saxony, Germany. Ticks Tick-Borne Dis. 2017;8:922-927.

63. Sykes JE. Lyme borreliosis. In: Sykes JE editions. Canine and feline infectious diseases. St. Louis, Elsevier. 2014:487-497.

64. Taenzler J, Gale B, Zschiesche E et coll. The effect of water and shampooing on the efficacy of fluralaner spot-on solution against Ixodes ricinus and Ctenocephalides felis infestations in dogs. Parasit. Vectors. 2016;9:233.

65. Topfer KH, Straubinger RK. Characterization of the humoral immune response in dogs after vaccination against the Lyme borreliosis agent: a study with five commercial vaccines using two different vaccination schedules. Vaccine. 2007;25:314-326.

66. Wagner B, Johnson J, Garcia-Tapia D et coll. Comparison of effectiveness of cefovecin, doxycycline, and amoxicillin for the treatment of experimentally induced early Lyme borreliosis in dogs. BMC Vet. Res. 2015;11:163.

67. Wengenmayer C, Williams H, Zschiesche E et coll. The speed of kill of fluralaner (Bravecto®) against Ixodes ricinus ticks on dogs. Parasit. Vectors. 2014;7:525.

 

 

TORNA INDIETRO
Abbonati per accedere

Dal web internazionale
13/04/2021

Virus dell'epatite E: prima descrizione in un coniglio domestico. Una nuova via

In questo lavoro, gli autori hanno identificato per la prima volta il virus dell'epatite E (HEV) in un coniglio domestico: una femmina adulta di 7 anni di coniglio domestico (Oryctolagus cuniculus).

 
 
Formazione a distanza abbinata a SUMMA

SPC-sviluppo-professionale-continuo